Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

Research output: Contribution to journalJournal article

Original languageEnglish
JournalDiabetes, Obesity and Metabolism
Volume20
Issue number8
Pages (from-to)1937-1943
ISSN1462-8902
DOIs
Publication statusPublished - Aug 2018

ID: 195511796